This application is a National Stage Application of PCT/EP13/069860 under 35 USC §371 (a), which claims priority of French Patent Application Serial No. 12/58983 filed Sep. 25, 2012, the disclosures of each of the above-identified applications are hereby incorporated by reference in their entirety.
The present invention relates to a prosthesis for medical or surgical use.
In the treatment of parietal insufficiencies, such as hernias and incisional hernias, the role of the prosthesis is to provide mechanical support to the surgical reconstruction. The prosthesis is often in the form of a piece of biocompatible textile which may or may not be accompanied by additional elements such as a coating in the form of a film, a set of needles, etc. The prosthesis is all the more effective, and its local tolerance all the better, if it integrates in the tissue intimately and at an early stage. To achieve intimate and early integration without formation of a peripheral fibrous shell, the pores of the prosthesis must be as widely open as possible to the outside, and its elasticity must allow it to follow the physiological deformations of the wall.
In a known manner, such prostheses, also called prosthetic fabrics or knits, have to meet a number of requirements, and in particular they need to have a mechanical strength in at least two perpendicular directions, be biocompatible, flexible and conformable, while having a certain capacity for elongation, in at least one direction, be porous and able to be sutured and recut, while at the same time being non-tear and run-proof, and, finally, they must be sterilizable. In general, the prostheses are knitted and made up of several sheets of interlaced yarns in order to meet all of these requirements. Thus, a large amount of foreign material is present in the long term in the body of the patient when the prosthetic material is not absorbable. This is undesirable, since the foreign material is likely to cause inflammation or fibrous shells in the body of the patient.
There is therefore a need for a prosthesis which has sufficient mechanical strength at least during the period of cell recolonization and which avoids any risk of recurrence, while at the same time having minimal material, and which can be put in place simply and quickly.
There is also a need for a prosthesis that would favour cell colonization and that may be secured to the biological tissues with fixation means such as staples or stitches without risking to damage the mesh forming the prosthesis or to create local tears, and if possible while implanting as less as possible of foreign material in the body of the patient.
The present invention aims to solve at least one of these problems by making available a prosthesis for medical or surgical use, comprising at least one porous mesh made of biocompatible material, said mesh comprising a first face and a second face opposite the first face, the prosthesis additionally comprising:
In the present document, “mesh” is understood as an arrangement or assembly of biocompatible yarns, fibres, monofilaments and/or multifilaments, for example a knit, woven fabric, nonwoven fabric, preferably openworked, that is to say provided with pores that promote cell recolonization. The mesh is sufficiently flexible to be folded back on itself at the time of its introduction into the biological cavity. The mesh can be produced from one or more layers of yarn arrangements. Such meshes are well known to a person skilled in the art. The mesh that can be used according to the invention can be supplied in any shape, e.g. rectangular, square, circular, oval, etc., and can then be cut in order to be adapted to the shape of the hernia defect. For example, the mesh can have the general shape of a disc or an oval. Alternatively, the mesh can have a generally square or rectangular shape.
In the present invention, the adjective “porous” refers to a material having pores, voids or alveoli that promote cell colonization. The larger the pores of the mesh, the greater its ability to allow cell colonization.
In the present document, “strengthening means” is understood as a means of modifying, in particular increasing, the mechanical strength of the mesh in at least one direction, preferably in at least two perpendicular directions. For example, if the mesh is a knit, the strengthening means can increase the tear strength and/or the resistance to elongation in multiple directions.
In the present document, “fastening means” is understood as a means permitting reversible fixation of the strengthening means to the mesh, so as to permit detachment by pulling, for example, on the strengthening means. Of course, renewed fixation of the strengthening means, for example for repositioning, is possible at the time of manufacture of the prosthesis according to the invention.
Thus, the means of fastening the mesh according to the invention gives the prosthesis locally different mechanical properties, making it possible to treat parietal insufficiencies according to local specific stresses. Moreover, the possibility of covering only part of the mesh makes it possible to limit the quantity of foreign material of the prosthesis of the invention compared to a prosthesis of which the mesh is completely covered. Moreover, the fastening means according to the invention permit reversible fixation of the strengthening means, which can thus be repositioned on the mesh.
In addition, the prosthesis of the invention, allows an excellent cell recolonization with as less as possible of implanted foreign material in the biological tissues, together with a high resitance against potential tearing or rupture of the mesh.
It is conceivable that these prostheses according to the invention are supplied in modular form with, on the one hand, a mesh and, on the other hand, a strengthening means to be fastened to the mesh.
The strengthening means of the invention can be in any conceivable form, for example in any geometric shape, such as an oval, circle, rectangle, square, etc.
The mesh and the strengthening means according to the invention can also be made available in the form of a band, such that the elements of the prosthesis can be cut out in the required dimensions before fastening them.
Moreover, the prosthesis according to the invention can be supplied in an already defined form, with the strengthening means already positioned on and fastened to the mesh.
The strengthening means is porous, and the pores of the mesh have dimensions larger than those of the pores of the strengthening means. Thus, the presence of the strengthening means on a localized part of the mesh gives the prosthesis mechanical strength and reduces the capacity for elongation in a region of the prosthesis designed to effectively fill a tissue defect. In the other regions, which are not intended to fill a defect, a mesh with less mechanical strength may suffice. It is thus possible to use a mesh with large pores facilitating cell colonization and reducing the overall quantity of foreign material in the body of the patient.
Preferably, the strengthening means comprises at least one piece of textile made of biocompatible material. In the present document, “textile” is understood as an arrangement or assembly of biocompatible yarns, fibres, monofilaments and/or multifilaments, for example a knit, woven fabric and nonwoven fabric. In one embodiment, the textile is a knit. In another embodiment, the textile is a nonwoven fabric. The covering of a part of the mesh is thus facilitated by the flexibility of the textile, which can be easily dimensioned.
In one embodiment, the fastening means are situated on the strengthening means and/or on one or both of said first and second faces of the mesh. The strengthening means is then easily fastened to one of the faces of the mesh.
Preferably, the fastening means comprise barbs. In the present document, “barb” means any hook made of any biocompatible material and integral with the arrangement of yarns forming the mesh or with the arrangement of yarns forming the strengthening means when the latter is in the form of a piece of textile, whether these hooks have been incorporated in said arrangement during manufacture (braiding, knitting, weaving etc.) or have been added afterwards. Examples of knits comprising such barbs are described in the document WO01/81667.
The presence of the barbs is advantageous in that they allow the textile of the strengthening means to be locked onto the mesh. This locking, which is effective even in a liquid environment, is sufficient to ensure the fixation of the strengthening means to the mesh while at the same time permitting release of the strengthening means in order to adjust the position thereof with respect to the mesh if need be. This gives the prosthesis according to the invention great flexibility and a great capacity for adaptation.
In one embodiment, the strengthening means comprises a bioabsorbable material, and the mesh comprises a partially bioabsorbable material.
In the present document, “bioabsorbable” or “biodegradable” is understood as the characteristic by which a material is absorbed and degraded by the biological tissues and disappears in vivo after a given period which, for example, can vary from several hours to several months, depending on the chemical nature of the material.
Thus, the bioabsorbable materials suitable for the yarns of the mesh or of the textile of the strengthening means of the present invention can be chosen from among polylactic acid (PLA), polyglycolic acid (PGA), oxidized cellulose, chitosan, polyphosphazene, polycaprolactone (PCL), polydioxanone (PDO), trimethylene carbonate (TMC), polyvinyl alcohol (PVA), polyhydroxyalkanoates (PHAs), polyamides, polyethers, copolymers thereof, and mixtures thereof. In the present invention, “partially bioabsorbable” refers to a material formed by the combination of a bioabsorbable material and of a non-bioabsorbable material.
The non-bioabsorbable materials suitable for the mesh and the textile of the strengthening means of the present invention can be chosen from among polyethylene terephthalate (PET), polyamides, aramids, expanded polytetrafluoroethylene, polyurethane, polyvinylidene difluoride (PVDF), polybutyl esters, PEEK (polyether ether ketone), polyolefins (such as polyethylene or polypropylene), copper alloys, silver alloys, platinum, medical grades of steel such as medical-grade stainless steel, and combinations thereof.
In another embodiment, the mesh is composed of a single material, in particular a partially bioabsorbable material.
Alternatively or in addition, the strengthening means is composed of a single material, in particular a bioabsorbable material.
In the configuration in which the mesh is composed of only a single partially bioabsorbable material and in which the strengthening means is composed of only a single bioabsorbable material, the prosthesis introduced into the human body initially comprises both the material of the mesh and also that of the strengthening means. During the weeks following the implantation, in particular permitting cell colonization, the bioabsorbable material disappears and the partially bioabsorbable material disappears in part. Thus, when the tissue defect has been filled by the cell recolonization, the materials constituting the prosthesis disappear at least partially. The overall quantity of residual foreign material in the body is thus greatly reduced. More precisely, the material of the strengthening means of the mesh is intended to completely disappear once the strengthening of the mesh has been rendered superfluous by the repair of the biological tissue. The material of the mesh is intended to partially disappear, so as to provide a minimal reinforcement over the entirety of the surface of the biological tissue treated by the prosthesis. This makes it possible to avoid any risk of recurrence, while at the same time permitting a reduction in the quantity of residual foreign material.
According to one alternative, the strengthening means comprises a partially bioabsorbable material, and the mesh comprises a bioabsorbable material.
According to one embodiment, the strengthening means is composed of a single material, in particular a partially bioabsorbable material.
Alternatively, the mesh is composed of a single material, in particular a bioabsorbable material.
Advantageously, the configuration in which the strengthening means is composed of a single partially bioabsorbable material, and in which the mesh is composed of a single bioabsorbable material, is intended for a case where it is chiefly necessary to maintain local reinforcement of the biological tissue and not reinforcement over the entirety of the surface of the prosthesis.
If necessary, the strengthening means may also be used to reinforce a central part fo the mesh. According to one embodiment, in a position fastened to the mesh, the strengthening means further covers a central part of one of said first and second faces of the mesh. With this configuration, it is possible to use a mesh of which the pores are of a considerable size. Indeed, the mechanical performance of the mesh, potentially reduced on account of the large size of the pores, is specifically compensated at the centre of the prosthesis by the strengthening means. Thus, the tissue integration of the prosthesis is improved without thereby compromising the reinforcement function needed at its centre to avoid a recurrence.
According to a embodiment, the strengthening means is made of partially bioabsorbable material and covers the central part of the mesh made of bioabsorbable material of which the size of the pores is greater than that of the pores of the strengthening means. This configuration is advantageous in that the mesh is reinforced at its centre and may thus have pores of greater dimensions. Moreover, the material of the mesh disappears over the course of time, whereas that of the strengthening means disappears partially in order to retain a sufficient mechanical stability in the area of the tissue defect, while limiting the quantity of foreign material present in the long term in the human body.
According to another configuration, it is advantageous to make available a prosthesis comprising a strengthening means made of bioabsorbable material covering the central part of the mesh made of partially absorbable material of which the size of the pores is larger than that of the pores of the strengthening means. The central reinforcement of the prosthesis is thus provided during the period of tissue rehabilitation, and the mesh with large pores remains partially on the entirety of the surface of the initial prosthesis while reducing the quantity of residual foreign material in the body.
In a position fastened to the mesh, the strengthening means covers a peripheral part of one of said first and second faces of the mesh. This configuration is particularly advantageous when the peripheral part of the prosthesis is intended to be fixed by staples or sutures to the biological wall. Indeed, the operation of stapling or suturing the mesh is susceptible to damaging the latter and even causing a local tear. Even though the mesh is designed so as not to propagate this tear, the presence of the strengthening means on the peripheral part of the mesh permits its mechanical reinforcement and affords added safety. This configuration makes it possible in fact to distribute, between the mesh and the strengthening means, the very local forces applied by the suturing or stapling of the prosthesis to the wall. Moreover, this peripheral reinforcement facilitates the deployment and positioning of the prosthesis by local stiffening of the mesh.
When covering a peripheral part of the mesh, it is possible to use a mesh with large pores and made of a partially absorbable material combined with a strengthening means made of bioabsorbable material, such that the strengthening means disappears once the prosthesis has been fixed to the biological wall.
In a configuration in which the size of the pores of the strengthening means is smaller than the size of the pores of the mesh, and the size of the pores of the mesh is too large to permit stapling, it is also very advantageous to use a strengthening means covering a peripheral part of the mesh.
According to one embodiment, at least a part of the strengthening means comprises a colour distinct from that of the mesh. This makes it easier for the surgeon to position and fix the prosthesis despite the lack of space and lack of visibility of the operating site. For example, when the strengthening means covers the peripheral part of the mesh, it is easy to identify the peripheral edges of the prosthesis according to the invention in order to fix it to the biological wall.
In one embodiment, the colour of the textile of the strengthening means and the colour of the mesh generate a contrast of 50% to 100%, preferably of 70% to 100%, according to the scale of contrast sensitivity defined for public buildings. In the present application, the contrast is determined according to the scale of contrast sensitivity (Functional Acuity Contrast Test) defined for public buildings by Dr Arthur Ginsburg, illustrated by Table I below:
As will be seen from Table I above, the textile colour/mesh colour combinations suitable for the prosthesis of the invention can be chosen from among the following combinations: beige/red, beige/blue, beige/green, beige/purple, beige/pink, beige/brown, beige/black, beige/grey, white/red, white/blue, white/orange, white/green, white/purple, white/pink, white/brown, white/black, white/grey, grey/yellow, grey/black, black/yellow, black/orange, black/green, black/purple, black/pink, brown/yellow, brown/orange, brown/pink, pink/red, pink/yellow, pink/blue, purple/yellow, green/yellow, green/orange, orange/red, orange/yellow, orange/blue, blue/yellow, yellow/red.
Advantageously, the prosthesis comprises fixing means intended to fix the prosthesis to biological tissues. It is thus easy to fix the prosthesis according to the invention without having to use external elements such as staples, and without the need for suture points.
According to one embodiment, the fixing means are situated on the strengthening means and/or on one or both of said first and second faces of the mesh. This permits reinforced fixing of the prosthesis to biological tissue. For example, when the strengthening means is positioned between the biological wall and the mesh, the surface of the strengthening means and the surface of the mesh in contact with the wall to be strengthened can both have fixing means, so as to reinforce the fixing of the prosthesis to the wall.
The fixing means preferably comprise barbs. They are easily produced from the mesh and from the strengthening means by techniques well known to a person skilled in the art. Thus, when the fastening means are also barbs, the fastening means can have the function of the fixing means, and vice versa. The use of the prosthesis is thereby simplified.
Other aspects, aims and advantages of the present invention will become clearer from reading the following description of three embodiments thereof, which description is given as a non-limiting example and with reference to the attached drawings. In order to improve their legibility, the figures do not necessarily reflect the scale of all the elements shown. To make matters simpler in the remainder of the description, identical, similar or equivalent elements in the different embodiments bear the same reference numbers.
The piece of textile 3 is fastened to the central part 4 of the mesh 2 by fastening means such as barbs 5, which are shown in
According to another variant not shown, the barbs 5 are present on the first face of the mesh 2 for fastening to the strengthening means, for example the piece of textile 3. According to yet another possibility not shown, the barbs 5 are present on the first and second faces of the mesh 2. The barbs 5 of one of the faces of the mesh 2 can also serve there as means for fixing to biological tissues.
According to another combination not shown, the barbs 5 are present on the first and second faces of the mesh 2 and on the strengthening means, for example the piece of textile 3.
According to one possibility not visible in the figures, the material of the mesh 2 is composed of a bioabsorbable material, and the material of the strengthening means, for example the piece of textile 3, is composed of a partially bioabsorbable material. Over the course of time, the mesh 2 disappears and the residual non-bioabsorbable part of the strengthening means (for example the piece of textile 3) continues to strengthen the region of the tissue defect.
As is shown in
It is also conceivable that the face of the strengthening means, for example the piece of textile 3, in contact with the biological tissue is covered by barbs 5 for additional fixation (not shown).
In one variant, barbs 5 can be provided on the first and second faces of the mesh 2, as is shown in
Thus, the prosthesis 1 of the invention can have any type of shape and can be manufactured very easily. The prosthesis 1 is simple to use and advantageously leaves little residual foreign material in the body of the patient.
It goes without saying that the invention is not limited to the embodiments described above by way of example and instead comprises all the technical equivalents and the variants of the means described and their combinations.
Number | Date | Country | Kind |
---|---|---|---|
12 58983 | Sep 2012 | FR | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/EP2013/069860 | 9/24/2013 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2014/048922 | 4/3/2014 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
1187158 | Mcginley | Jun 1916 | A |
3054406 | Usher | Sep 1962 | A |
3118294 | Van Laethem | Jan 1964 | A |
3124136 | Usher | Mar 1964 | A |
3272204 | Charles et al. | Sep 1966 | A |
3276448 | Usher | Oct 1966 | A |
3320649 | Naimer | May 1967 | A |
3364200 | Ashton et al. | Jan 1968 | A |
3570482 | Emoto et al. | Mar 1971 | A |
3718725 | Hamano | Feb 1973 | A |
4006747 | Kronenthal et al. | Feb 1977 | A |
4060081 | Yannas et al. | Nov 1977 | A |
4173131 | Pendergrass et al. | Nov 1979 | A |
4193137 | Heck | Mar 1980 | A |
4248064 | Odham | Feb 1981 | A |
4294241 | Miyata | Oct 1981 | A |
4307717 | Hymes et al. | Dec 1981 | A |
4338800 | Matsuda | Jul 1982 | A |
4476697 | Schafer et al. | Oct 1984 | A |
4487865 | Balazs et al. | Dec 1984 | A |
4500676 | Balazs et al. | Feb 1985 | A |
4511653 | Play et al. | Apr 1985 | A |
4527404 | Nakagaki et al. | Jul 1985 | A |
4591501 | Cioca | May 1986 | A |
4597762 | Walter et al. | Jul 1986 | A |
4603695 | Ikada et al. | Aug 1986 | A |
4631932 | Sommers | Dec 1986 | A |
4670014 | Huc et al. | Jun 1987 | A |
4709562 | Matsuda | Dec 1987 | A |
4748078 | Doi et al. | May 1988 | A |
4759354 | Quarfoot | Jul 1988 | A |
4769038 | Bendavid et al. | Sep 1988 | A |
4796603 | Dahlke et al. | Jan 1989 | A |
4813942 | Alvarez | Mar 1989 | A |
4841962 | Berg et al. | Jun 1989 | A |
4854316 | Davis | Aug 1989 | A |
4925294 | Geshwind et al. | May 1990 | A |
4931546 | Tardy et al. | Jun 1990 | A |
4942875 | Hlavacek et al. | Jul 1990 | A |
4948540 | Nigam | Aug 1990 | A |
4950483 | Ksander et al. | Aug 1990 | A |
4970298 | Silver et al. | Nov 1990 | A |
4976737 | Leake | Dec 1990 | A |
5002551 | Linsky et al. | Mar 1991 | A |
5015584 | Brysk | May 1991 | A |
5116357 | Eberbach | May 1992 | A |
5147374 | Fernandez | Sep 1992 | A |
5162430 | Rhee et al. | Nov 1992 | A |
5171273 | Silver et al. | Dec 1992 | A |
5176692 | Wilk et al. | Jan 1993 | A |
5192301 | Kamiya et al. | Mar 1993 | A |
5195542 | Gazielly et al. | Mar 1993 | A |
5196185 | Silver et al. | Mar 1993 | A |
5201745 | Tayot et al. | Apr 1993 | A |
5201764 | Kelman et al. | Apr 1993 | A |
5206028 | Li | Apr 1993 | A |
5217493 | Raad et al. | Jun 1993 | A |
5254133 | Seid | Oct 1993 | A |
5256418 | Kemp et al. | Oct 1993 | A |
5258000 | Gianturco | Nov 1993 | A |
5263983 | Yoshizato et al. | Nov 1993 | A |
5304595 | Rhee et al. | Apr 1994 | A |
5306500 | Rhee et al. | Apr 1994 | A |
5324775 | Rhee et al. | Jun 1994 | A |
5328955 | Rhee et al. | Jul 1994 | A |
5334527 | Brysk | Aug 1994 | A |
5339657 | McMurray | Aug 1994 | A |
5350583 | Yoshizato et al. | Sep 1994 | A |
5356432 | Rutkow et al. | Oct 1994 | A |
5368549 | McVicker | Nov 1994 | A |
5368602 | de la Torre | Nov 1994 | A |
5370650 | Tovey et al. | Dec 1994 | A |
5376375 | Rhee et al. | Dec 1994 | A |
5376376 | Li | Dec 1994 | A |
5397331 | Himpens et al. | Mar 1995 | A |
5399361 | Song et al. | Mar 1995 | A |
5413791 | Rhee et al. | May 1995 | A |
5425740 | Hutchinson, Jr. | Jun 1995 | A |
5428022 | Palefsky et al. | Jun 1995 | A |
5433996 | Kranzler et al. | Jul 1995 | A |
5441491 | Verschoor et al. | Aug 1995 | A |
5441508 | Gazielly et al. | Aug 1995 | A |
5456693 | Conston et al. | Oct 1995 | A |
5456711 | Hudson | Oct 1995 | A |
5466462 | Rosenthal et al. | Nov 1995 | A |
5480644 | Freed | Jan 1996 | A |
5487895 | Dapper et al. | Jan 1996 | A |
5490984 | Freed | Feb 1996 | A |
5512291 | Li | Apr 1996 | A |
5512301 | Song et al. | Apr 1996 | A |
5514181 | Light et al. | May 1996 | A |
5522840 | Krajicek | Jun 1996 | A |
5523348 | Rhee et al. | Jun 1996 | A |
5536656 | Kemp et al. | Jul 1996 | A |
5543441 | Rhee et al. | Aug 1996 | A |
5565210 | Rosenthal et al. | Oct 1996 | A |
5567806 | Abdul-Malak et al. | Oct 1996 | A |
5569273 | Titone et al. | Oct 1996 | A |
RE35399 | Eisenberg | Dec 1996 | E |
5593441 | Lichtenstein et al. | Jan 1997 | A |
5595621 | Light et al. | Jan 1997 | A |
5601571 | Moss | Feb 1997 | A |
5607474 | Athanasiou et al. | Mar 1997 | A |
5607590 | Shimizu | Mar 1997 | A |
5614587 | Rhee et al. | Mar 1997 | A |
5618551 | Tardy et al. | Apr 1997 | A |
5634931 | Kugel | Jun 1997 | A |
5639796 | Lee | Jun 1997 | A |
5665391 | Lea | Sep 1997 | A |
5667839 | Berg | Sep 1997 | A |
5676967 | Williams et al. | Oct 1997 | A |
5681568 | Goldin et al. | Oct 1997 | A |
5686090 | Schilder et al. | Nov 1997 | A |
5686115 | Vournakis et al. | Nov 1997 | A |
5690675 | Sawyer et al. | Nov 1997 | A |
5695525 | Mulhauser et al. | Dec 1997 | A |
5697978 | Sgro | Dec 1997 | A |
5700476 | Rosenthal et al. | Dec 1997 | A |
5700477 | Rosenthal et al. | Dec 1997 | A |
5702416 | Kieturakis et al. | Dec 1997 | A |
5709934 | Bell et al. | Jan 1998 | A |
5711960 | Shikinami | Jan 1998 | A |
5716409 | Debbas | Feb 1998 | A |
5720981 | Eisinger | Feb 1998 | A |
5732572 | Litton | Mar 1998 | A |
5743917 | Saxon | Apr 1998 | A |
5749895 | Sawyer et al. | May 1998 | A |
5752974 | Rhee et al. | May 1998 | A |
5766246 | Mulhauser et al. | Jun 1998 | A |
5766631 | Arnold | Jun 1998 | A |
5769864 | Kugel | Jun 1998 | A |
5771716 | Schlussel | Jun 1998 | A |
5785983 | Furlan et al. | Jul 1998 | A |
5800541 | Rhee et al. | Sep 1998 | A |
5814328 | Gunasekaran | Sep 1998 | A |
5833705 | Ken et al. | Nov 1998 | A |
5840011 | Landgrebe et al. | Nov 1998 | A |
5861034 | Taira et al. | Jan 1999 | A |
5863984 | Doillon et al. | Jan 1999 | A |
5869080 | McGregor et al. | Feb 1999 | A |
5871767 | Dionne et al. | Feb 1999 | A |
5876444 | Lai | Mar 1999 | A |
5891558 | Bell et al. | Apr 1999 | A |
5899909 | Claren et al. | May 1999 | A |
5906937 | Sugiyama et al. | May 1999 | A |
5910149 | Kuzmak | Jun 1999 | A |
5911731 | Pham et al. | Jun 1999 | A |
5916225 | Kugel | Jun 1999 | A |
5919232 | Chaffringeon et al. | Jul 1999 | A |
5919233 | Knopf et al. | Jul 1999 | A |
5922026 | Chin | Jul 1999 | A |
5931165 | Reich et al. | Aug 1999 | A |
5942278 | Hagedorn et al. | Aug 1999 | A |
5962136 | Dewez et al. | Oct 1999 | A |
5972022 | Huxel | Oct 1999 | A |
RE36370 | Li | Nov 1999 | E |
5993844 | Abraham et al. | Nov 1999 | A |
5994325 | Roufa et al. | Nov 1999 | A |
5997895 | Narotam et al. | Dec 1999 | A |
6001895 | Harvey et al. | Dec 1999 | A |
6008292 | Lee et al. | Dec 1999 | A |
6015844 | Harvey et al. | Jan 2000 | A |
6039686 | Kovac | Mar 2000 | A |
6042534 | Gellman et al. | Mar 2000 | A |
6042592 | Schmitt | Mar 2000 | A |
6043089 | Sugiyama et al. | Mar 2000 | A |
6051425 | Morota et al. | Apr 2000 | A |
6056688 | Benderev et al. | May 2000 | A |
6056970 | Greenawalt et al. | May 2000 | A |
6057148 | Sugiyama et al. | May 2000 | A |
6063396 | Kelleher | May 2000 | A |
6066776 | Goodwin et al. | May 2000 | A |
6066777 | Benchetrit | May 2000 | A |
6071292 | Makower et al. | Jun 2000 | A |
6077281 | Das | Jun 2000 | A |
6080194 | Pachence et al. | Jun 2000 | A |
6083522 | Chu et al. | Jul 2000 | A |
6090116 | D'Aversa et al. | Jul 2000 | A |
6113623 | Sgro | Sep 2000 | A |
6120539 | Eldridge et al. | Sep 2000 | A |
6132765 | DiCosmo et al. | Oct 2000 | A |
6143037 | Goldstein et al. | Nov 2000 | A |
6153292 | Bell et al. | Nov 2000 | A |
6162962 | Hinsch et al. | Dec 2000 | A |
6165488 | Tardy et al. | Dec 2000 | A |
6171318 | Kugel et al. | Jan 2001 | B1 |
6174320 | Kugel et al. | Jan 2001 | B1 |
6176863 | Kugel et al. | Jan 2001 | B1 |
6179872 | Bell et al. | Jan 2001 | B1 |
6180848 | Flament et al. | Jan 2001 | B1 |
6197325 | MacPhee et al. | Mar 2001 | B1 |
6197934 | DeVore et al. | Mar 2001 | B1 |
6197935 | Doillon et al. | Mar 2001 | B1 |
6210439 | Firmin et al. | Apr 2001 | B1 |
6214020 | Mulhauser et al. | Apr 2001 | B1 |
6221109 | Geistlich et al. | Apr 2001 | B1 |
6224616 | Kugel | May 2001 | B1 |
6241768 | Agarwal et al. | Jun 2001 | B1 |
6258124 | Darois et al. | Jul 2001 | B1 |
6262332 | Ketharanathan | Jul 2001 | B1 |
6264702 | Ory et al. | Jul 2001 | B1 |
6267772 | Mulhauser et al. | Jul 2001 | B1 |
6270530 | Eldridge et al. | Aug 2001 | B1 |
6277397 | Shimizu | Aug 2001 | B1 |
6280453 | Kugel et al. | Aug 2001 | B1 |
6287316 | Agarwal et al. | Sep 2001 | B1 |
6290708 | Kugel et al. | Sep 2001 | B1 |
6306079 | Trabucco | Oct 2001 | B1 |
6306424 | Vyakarnam et al. | Oct 2001 | B1 |
6312474 | Francis et al. | Nov 2001 | B1 |
6319264 | Tormala et al. | Nov 2001 | B1 |
6328686 | Kovac | Dec 2001 | B1 |
6334872 | Termin et al. | Jan 2002 | B1 |
6383201 | Dong | May 2002 | B1 |
6391060 | Ory et al. | May 2002 | B1 |
6391333 | Li et al. | May 2002 | B1 |
6391939 | Tayot et al. | May 2002 | B2 |
6408656 | Ory et al. | Jun 2002 | B1 |
6410044 | Chudzik et al. | Jun 2002 | B1 |
6413742 | Olsen et al. | Jul 2002 | B1 |
6425924 | Rousseau | Jul 2002 | B1 |
6428978 | Olsen et al. | Aug 2002 | B1 |
6436030 | Rehil | Aug 2002 | B2 |
6440167 | Shimizu | Aug 2002 | B2 |
6443964 | Ory et al. | Sep 2002 | B1 |
6447551 | Goldmann | Sep 2002 | B1 |
6447802 | Sessions et al. | Sep 2002 | B2 |
6448378 | DeVore et al. | Sep 2002 | B2 |
6451032 | Ory et al. | Sep 2002 | B1 |
6451301 | Sessions et al. | Sep 2002 | B1 |
6454787 | Maddalo et al. | Sep 2002 | B1 |
6477865 | Matsumoto | Nov 2002 | B1 |
6479072 | Morgan et al. | Nov 2002 | B1 |
6485503 | Jacobs et al. | Nov 2002 | B2 |
6500464 | Ceres et al. | Dec 2002 | B2 |
6500777 | Wiseman et al. | Dec 2002 | B1 |
6509031 | Miller et al. | Jan 2003 | B1 |
6511958 | Atkinson et al. | Jan 2003 | B1 |
6514286 | Leatherbury et al. | Feb 2003 | B1 |
6514514 | Atkinson et al. | Feb 2003 | B1 |
6540773 | Dong | Apr 2003 | B2 |
6541023 | Andre et al. | Apr 2003 | B1 |
6548077 | Gunasekaran | Apr 2003 | B1 |
6554855 | Dong | Apr 2003 | B1 |
6559119 | Burgess et al. | May 2003 | B1 |
6566345 | Miller et al. | May 2003 | B2 |
6575988 | Rousseau | Jun 2003 | B2 |
6576019 | Atala | Jun 2003 | B1 |
6596002 | Therin et al. | Jul 2003 | B2 |
6596304 | Bayon et al. | Jul 2003 | B1 |
6599323 | Melican et al. | Jul 2003 | B2 |
6599524 | Li et al. | Jul 2003 | B2 |
6599690 | Abraham et al. | Jul 2003 | B1 |
6610006 | Amid et al. | Aug 2003 | B1 |
6613348 | Jain | Sep 2003 | B1 |
6616685 | Rousseau | Sep 2003 | B2 |
6623963 | Muller et al. | Sep 2003 | B1 |
6630414 | Matsumoto | Oct 2003 | B1 |
6637437 | Hungerford et al. | Oct 2003 | B1 |
6638284 | Rousseau et al. | Oct 2003 | B1 |
6645226 | Jacobs et al. | Nov 2003 | B1 |
6652594 | Francis et al. | Nov 2003 | B2 |
6652595 | Nicolo | Nov 2003 | B1 |
6653450 | Berg et al. | Nov 2003 | B1 |
6656206 | Corcoran et al. | Dec 2003 | B2 |
6660280 | Allard et al. | Dec 2003 | B1 |
6669735 | Pelissier | Dec 2003 | B1 |
6670018 | Fujita et al. | Dec 2003 | B2 |
6682760 | Noff et al. | Jan 2004 | B2 |
6685714 | Rousseau | Feb 2004 | B2 |
6706684 | Bayon et al. | Mar 2004 | B1 |
6706690 | Reich et al. | Mar 2004 | B2 |
6712859 | Rousseau et al. | Mar 2004 | B2 |
6719795 | Cornwall et al. | Apr 2004 | B1 |
6723335 | Moehlenbruck et al. | Apr 2004 | B1 |
6726660 | Hessel et al. | Apr 2004 | B2 |
6730299 | Tayot et al. | May 2004 | B1 |
6736823 | Darois et al. | May 2004 | B2 |
6736854 | Vadurro et al. | May 2004 | B2 |
6737371 | Planck et al. | May 2004 | B1 |
6743435 | DeVore et al. | Jun 2004 | B2 |
6746458 | Cloud | Jun 2004 | B1 |
6752834 | Geistlich et al. | Jun 2004 | B2 |
6755868 | Rousseau | Jun 2004 | B2 |
6773723 | Spiro et al. | Aug 2004 | B1 |
6783554 | Amara et al. | Aug 2004 | B2 |
6790213 | Cherok et al. | Sep 2004 | B2 |
6790454 | Abdul Malak et al. | Sep 2004 | B1 |
6800082 | Rousseau | Oct 2004 | B2 |
6833408 | Sehl et al. | Dec 2004 | B2 |
6835336 | Watt | Dec 2004 | B2 |
6852330 | Bowman et al. | Feb 2005 | B2 |
6869938 | Schwartz et al. | Mar 2005 | B1 |
6872227 | Sump et al. | Mar 2005 | B2 |
6893653 | Abraham et al. | May 2005 | B2 |
6896904 | Spiro et al. | May 2005 | B2 |
6926723 | Mulhauser et al. | Aug 2005 | B1 |
6936276 | Spiro et al. | Aug 2005 | B2 |
6939562 | Spiro et al. | Sep 2005 | B2 |
6949625 | Tayot | Sep 2005 | B2 |
6966918 | Schuldt-Hempe et al. | Nov 2005 | B1 |
6971252 | Therin et al. | Dec 2005 | B2 |
6974679 | Andre et al. | Dec 2005 | B2 |
6974862 | Ringeisen et al. | Dec 2005 | B2 |
6977231 | Matsuda | Dec 2005 | B1 |
6984392 | Bechert et al. | Jan 2006 | B2 |
6988386 | Okawa et al. | Jan 2006 | B1 |
7011688 | Gryska et al. | Mar 2006 | B2 |
7021086 | Ory et al. | Apr 2006 | B2 |
7022358 | Eckmayer et al. | Apr 2006 | B2 |
7025063 | Snitkin et al. | Apr 2006 | B2 |
7041868 | Greene et al. | May 2006 | B2 |
7060103 | Carr, Jr. et al. | Jun 2006 | B2 |
RE39172 | Bayon et al. | Jul 2006 | E |
7070558 | Gellman et al. | Jul 2006 | B2 |
7087065 | Ulmsten et al. | Aug 2006 | B2 |
7094261 | Zotti et al. | Aug 2006 | B2 |
7098315 | Schaufler | Aug 2006 | B2 |
7101381 | Ford et al. | Sep 2006 | B2 |
7115220 | Dubson et al. | Oct 2006 | B2 |
7156804 | Nicolo | Jan 2007 | B2 |
7156858 | Schuldt-Hempe et al. | Jan 2007 | B2 |
7175852 | Simmoteit et al. | Feb 2007 | B2 |
7192604 | Brown et al. | Mar 2007 | B2 |
7207962 | Anand et al. | Apr 2007 | B2 |
7214765 | Ringeisen et al. | May 2007 | B2 |
7226611 | Yura et al. | Jun 2007 | B2 |
7229453 | Anderson et al. | Jun 2007 | B2 |
7252837 | Guo et al. | Aug 2007 | B2 |
7279177 | Looney et al. | Oct 2007 | B2 |
7331199 | Ory et al. | Feb 2008 | B2 |
7393319 | Merade et al. | Jul 2008 | B2 |
7556598 | Rao | Jul 2009 | B2 |
7594921 | Browning | Sep 2009 | B2 |
7614258 | Cherok et al. | Nov 2009 | B2 |
7615065 | Priewe et al. | Nov 2009 | B2 |
7662169 | Wittmann | Feb 2010 | B2 |
7670380 | Cauthen, III | Mar 2010 | B2 |
7682381 | Rakos et al. | Mar 2010 | B2 |
7709017 | Tayot | May 2010 | B2 |
7718556 | Matsuda et al. | May 2010 | B2 |
7732354 | Fricke et al. | Jun 2010 | B2 |
7785334 | Ford et al. | Aug 2010 | B2 |
7789888 | Bartee et al. | Sep 2010 | B2 |
7799767 | Lamberti et al. | Sep 2010 | B2 |
7806905 | Ford et al. | Oct 2010 | B2 |
7824420 | Eldridge et al. | Nov 2010 | B2 |
7828854 | Rousseau et al. | Nov 2010 | B2 |
7900484 | Cherok et al. | Mar 2011 | B2 |
7931695 | Ringeisen | Apr 2011 | B2 |
8052759 | Dupic et al. | Nov 2011 | B2 |
8079023 | Chen | Dec 2011 | B2 |
8100924 | Browning | Jan 2012 | B2 |
8123817 | Intoccia et al. | Feb 2012 | B2 |
8142515 | Therin et al. | Mar 2012 | B2 |
8157821 | Browning | Apr 2012 | B2 |
8157822 | Browning | Apr 2012 | B2 |
8182545 | Cherok et al. | May 2012 | B2 |
8197837 | Jamiolkowski et al. | Jun 2012 | B2 |
8206632 | Rousseau et al. | Jun 2012 | B2 |
8215310 | Browning | Jul 2012 | B2 |
8317872 | Adams | Nov 2012 | B2 |
8323675 | Greenawalt | Dec 2012 | B2 |
8343232 | Adzich et al. | Jan 2013 | B2 |
8366787 | Brown et al. | Feb 2013 | B2 |
8435307 | Paul | May 2013 | B2 |
8470355 | Skalla et al. | Jun 2013 | B2 |
8562633 | Cully et al. | Oct 2013 | B2 |
8574627 | Martakos et al. | Nov 2013 | B2 |
8709094 | Stad et al. | Apr 2014 | B2 |
8734471 | Deitch | May 2014 | B2 |
8753360 | Gleiman et al. | Jun 2014 | B2 |
8758800 | Stopek et al. | Jun 2014 | B2 |
8784294 | Goddard | Jul 2014 | B2 |
8814887 | Walther et al. | Aug 2014 | B2 |
8828092 | Toso et al. | Sep 2014 | B2 |
8834864 | Odar et al. | Sep 2014 | B2 |
8846060 | Archibald et al. | Sep 2014 | B2 |
8865215 | Ladet et al. | Oct 2014 | B2 |
8877233 | Obermiller et al. | Nov 2014 | B2 |
8911504 | Mathisen et al. | Dec 2014 | B2 |
8920370 | Sholev et al. | Dec 2014 | B2 |
8956373 | Ford et al. | Feb 2015 | B2 |
8962006 | Bayon et al. | Feb 2015 | B2 |
8968762 | Ladet et al. | Mar 2015 | B2 |
8979935 | Lozier et al. | Mar 2015 | B2 |
9034357 | Stopek | May 2015 | B2 |
9113993 | Lee | Aug 2015 | B2 |
9211175 | Stopek et al. | Dec 2015 | B2 |
9216075 | Bailly et al. | Dec 2015 | B2 |
20020087174 | Capello | Jul 2002 | A1 |
20020095218 | Carr et al. | Jul 2002 | A1 |
20030086975 | Ringeisen | May 2003 | A1 |
20030106346 | Matsumoto | Jun 2003 | A1 |
20030114937 | Leatherbury et al. | Jun 2003 | A1 |
20030133967 | Ruszczak et al. | Jul 2003 | A1 |
20030225355 | Butler | Dec 2003 | A1 |
20040034373 | Schuldt-Hempe et al. | Feb 2004 | A1 |
20040054376 | Ory et al. | Mar 2004 | A1 |
20040059356 | Gingras | Mar 2004 | A1 |
20040101546 | Gorman et al. | May 2004 | A1 |
20050002893 | Goldmann | Jan 2005 | A1 |
20050021058 | Negro | Jan 2005 | A1 |
20050085924 | Darois et al. | Apr 2005 | A1 |
20050113849 | Popadiuk et al. | May 2005 | A1 |
20050137512 | Campbell et al. | Jun 2005 | A1 |
20050142161 | Freeman et al. | Jun 2005 | A1 |
20050148963 | Brennan | Jul 2005 | A1 |
20050175659 | Macomber et al. | Aug 2005 | A1 |
20050232979 | Shoshan | Oct 2005 | A1 |
20050267521 | Forsberg | Dec 2005 | A1 |
20050288691 | Leiboff | Dec 2005 | A1 |
20060116696 | Odermatt et al. | Jun 2006 | A1 |
20060135921 | Wiercinski et al. | Jun 2006 | A1 |
20060147501 | Hillas et al. | Jul 2006 | A1 |
20060216320 | Kitazono et al. | Sep 2006 | A1 |
20060252981 | Matsuda et al. | Nov 2006 | A1 |
20060253203 | Alvarado | Nov 2006 | A1 |
20060282103 | Fricke et al. | Dec 2006 | A1 |
20070088391 | McAlexander et al. | Apr 2007 | A1 |
20070129736 | Solecki | Jun 2007 | A1 |
20070198040 | Buevich et al. | Aug 2007 | A1 |
20070299538 | Roeber | Dec 2007 | A1 |
20080091276 | Deusch et al. | Apr 2008 | A1 |
20080109017 | Herweck et al. | May 2008 | A1 |
20080113001 | Herweck et al. | May 2008 | A1 |
20080172071 | Barker | Jul 2008 | A1 |
20080255593 | St-Germain | Oct 2008 | A1 |
20090035341 | Wagener et al. | Feb 2009 | A1 |
20090036996 | Roeber | Feb 2009 | A1 |
20090068250 | Gravagna et al. | Mar 2009 | A1 |
20090105526 | Piroli Torelli et al. | Apr 2009 | A1 |
20090163936 | Yang et al. | Jun 2009 | A1 |
20090187197 | Roeber et al. | Jul 2009 | A1 |
20090192530 | Adzich et al. | Jul 2009 | A1 |
20090204129 | Fronio | Aug 2009 | A1 |
20090216338 | Gingras et al. | Aug 2009 | A1 |
20090270999 | Brown | Oct 2009 | A1 |
20090281558 | Li | Nov 2009 | A1 |
20090318752 | Evans et al. | Dec 2009 | A1 |
20100104608 | Abuzaina et al. | Apr 2010 | A1 |
20100318108 | Datta et al. | Dec 2010 | A1 |
20110015760 | Kullas | Jan 2011 | A1 |
20110144667 | Horton et al. | Jun 2011 | A1 |
20110190795 | Hotter et al. | Aug 2011 | A1 |
20110238094 | Thomas et al. | Sep 2011 | A1 |
20110251699 | Ladet | Oct 2011 | A1 |
20110257666 | Ladet et al. | Oct 2011 | A1 |
20120016388 | Houard et al. | Jan 2012 | A1 |
20120029537 | Mortarino | Feb 2012 | A1 |
20120065727 | Reneker et al. | Mar 2012 | A1 |
20120082712 | Stopek et al. | Apr 2012 | A1 |
20120116425 | Intoccia et al. | May 2012 | A1 |
20120150204 | Mortarino et al. | Jun 2012 | A1 |
20120165937 | Montanari et al. | Jun 2012 | A1 |
20120179175 | Hammell | Jul 2012 | A1 |
20120179176 | Wilson et al. | Jul 2012 | A1 |
20120197415 | Montanari et al. | Aug 2012 | A1 |
20130158571 | Meneghin | Jun 2013 | A1 |
20140044861 | Boey et al. | Feb 2014 | A1 |
20140364684 | Lecuivre | Dec 2014 | A1 |
Number | Date | Country |
---|---|---|
1317836 | May 1993 | CA |
201879864 | Jun 2011 | CN |
19544162 | Apr 1997 | DE |
19718903 | Dec 1997 | DE |
19751733 | Dec 1998 | DE |
19832634 | Jan 2000 | DE |
10019604 | Oct 2001 | DE |
10120942 | Oct 2001 | DE |
10043396 | Jun 2002 | DE |
0194192 | Sep 1986 | EP |
0248544 | Dec 1987 | EP |
0263360 | Apr 1988 | EP |
0276890 | Aug 1988 | EP |
0372969 | Jun 1990 | EP |
0531742 | Mar 1993 | EP |
544485 | Jun 1993 | EP |
0552576 | Jul 1993 | EP |
0611561 | Aug 1994 | EP |
614650 | Sep 1994 | EP |
0621014 | Oct 1994 | EP |
0625891 | Nov 1994 | EP |
0637452 | Feb 1995 | EP |
0664132 | Jul 1995 | EP |
0705878 | Apr 1996 | EP |
0719527 | Jul 1996 | EP |
0774240 | May 1997 | EP |
0797962 | Oct 1997 | EP |
0800791 | Oct 1997 | EP |
827724 | Mar 1998 | EP |
0836838 | Apr 1998 | EP |
0847727 | Jun 1998 | EP |
0876808 | Nov 1998 | EP |
0895762 | Feb 1999 | EP |
898944 | Mar 1999 | EP |
1017415 | Jul 2000 | EP |
1036545 | Sep 2000 | EP |
1052319 | Nov 2000 | EP |
1055757 | Nov 2000 | EP |
1090590 | Apr 2001 | EP |
1 216 717 | Jun 2002 | EP |
1 216 718 | Jun 2002 | EP |
0693523 | Nov 2002 | EP |
1273312 | Jan 2003 | EP |
1315468 | Jun 2003 | EP |
1382728 | Jan 2004 | EP |
1484070 | Dec 2004 | EP |
1561480 | Aug 2005 | EP |
1645232 | Apr 2006 | EP |
1674048 | Jun 2006 | EP |
1691606 | Aug 2006 | EP |
1782848 | May 2007 | EP |
2229918 | Sep 2010 | EP |
2 305 132 | Apr 2011 | EP |
2404571 | Jan 2012 | EP |
2866729 | May 2015 | EP |
2244853 | Apr 1975 | FR |
2257262 | Aug 1975 | FR |
2 308 349 | Nov 1976 | FR |
2453231 | Oct 1980 | FR |
2612392 | Sep 1988 | FR |
2715309 | Jul 1995 | FR |
2715405 | Jul 1995 | FR |
2 724 563 | Mar 1996 | FR |
2730406 | Aug 1996 | FR |
2744906 | Aug 1997 | FR |
2766698 | Feb 1999 | FR |
2771622 | Jun 1999 | FR |
2773057 | Jul 1999 | FR |
2774277 | Aug 1999 | FR |
2779937 | Dec 1999 | FR |
2859624 | Mar 2005 | FR |
2863277 | Jun 2005 | FR |
2876020 | Apr 2006 | FR |
2884706 | Oct 2006 | FR |
2929834 | Oct 2009 | FR |
2953709 | Jun 2011 | FR |
2962645 | Jan 2012 | FR |
1174814 | Dec 1969 | GB |
2 051 153 | Jan 1981 | GB |
2306110 | Apr 1997 | GB |
H0332677 | Feb 1991 | JP |
H05237128 | Sep 1993 | JP |
H09137380 | May 1997 | JP |
H11146888 | Jun 1999 | JP |
2008538300 | Oct 2008 | JP |
2011078767 | Apr 2011 | JP |
8902445 | Mar 1989 | WO |
8908467 | Sep 1989 | WO |
9012551 | Nov 1990 | WO |
9206639 | Apr 1992 | WO |
9220349 | Nov 1992 | WO |
9311805 | Jun 1993 | WO |
9310731 | Jun 1993 | WO |
9318174 | Sep 1993 | WO |
9417747 | Aug 1994 | WO |
9507666 | Mar 1995 | WO |
9518638 | Jul 1995 | WO |
9532687 | Dec 1995 | WO |
9603091 | Feb 1996 | WO |
9608277 | Mar 1996 | WO |
9609795 | Apr 1996 | WO |
9614805 | May 1996 | WO |
9641588 | Dec 1996 | WO |
9735533 | Oct 1997 | WO |
9835632 | Aug 1998 | WO |
9849967 | Nov 1998 | WO |
9905990 | Feb 1999 | WO |
9906079 | Feb 1999 | WO |
9906080 | Feb 1999 | WO |
9951163 | Oct 1999 | WO |
0016821 | Mar 2000 | WO |
0067663 | Nov 2000 | WO |
0115625 | Mar 2001 | WO |
0180773 | Nov 2001 | WO |
0181667 | Nov 2001 | WO |
0207648 | Jan 2002 | WO |
0217853 | Mar 2002 | WO |
WO 0222047 | Mar 2002 | WO |
02078568 | Oct 2002 | WO |
03002168 | Jan 2003 | WO |
2004004600 | Jan 2004 | WO |
2004071349 | Aug 2004 | WO |
2004078120 | Sep 2004 | WO |
2004103212 | Dec 2004 | WO |
2005011280 | Feb 2005 | WO |
2005013863 | Feb 2005 | WO |
2005018698 | Mar 2005 | WO |
2005048708 | Jun 2005 | WO |
2005105172 | Nov 2005 | WO |
2006018552 | Feb 2006 | WO |
2006023444 | Mar 2006 | WO |
2007048099 | Apr 2007 | WO |
2009031035 | Mar 2009 | WO |
2009071998 | Jun 2009 | WO |
2010043978 | Apr 2010 | WO |
2011007062 | Jan 2011 | WO |
2011026987 | Mar 2011 | WO |
2011038740 | Apr 2011 | WO |
WO 2011119845 | Sep 2011 | WO |
2012007579 | Jan 2012 | WO |
2014001508 | Jan 2014 | WO |
Entry |
---|
Malette, W. G. et al., “Chitosan, A New Hemostatic,” Ann Th. Surg., Jul. 1983, pp. 55-58, 36. |
Langenbech, M. R. et al., “Comparison of biomaterials in the early postoperative period,” Surg Endosc., May 2003, pp. 1105-1109, 17 (7). |
Bracco, P. et al., “Comparison of polypropylene and polyethylene terephthalate (Dacron) meshes for abdominal wall hernia repair: A chemical and morphological study,” Hernia, 2005, pp. 51-55, 9 (1), published online Sep. 2004. |
Klinge, U. et al., “Foreign Body Reaction to Meshes Used for the Repair of Abdominal Wall Hernias,” Eur J. Surg, Sep. 1999, pp. 665-673, 165. |
Logeart, D. et al., “Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. II. Degradation and molecular weight effect,” Eur. J. Cell. Biol., Dec. 1997, pp. 385-390, 74(4). |
Haneji, K. et al., “Fucoidan extracted from Cladosiphon Okamuranus Tokida Induces Apoptosis of Human T-cell Leukemia Virus Type 1-Infected T-Cell Lines and Primary Adult T-Cell Leukemia Cells,” Nutrition and Cancer, 2005, pp. 189-201, 52(2), published online Nov. 2009. |
Junge, K. et al., “Functional and Morphologic Properties of a Modified Mesh for Inguinal Hernia Repair,” World J. Surg., Sep. 2002, pp. 1472-1480, 26. |
Klinge, U. et al., “Functional and Morphological Evaluation of a Low-Weight, Monofilament Polypropylene Mesh for Hernia Repair,” J. Biomed. Mater. Res., Jan. 2002, pp. 129-136, 63. |
Welty, G. et al., “Functional impairment and complaints following incisional hernia repair with different polypropylene meshes,” Hernia, Aug. 2001; pp. 142-147, 5. |
Varum, K. et al., “In vitro degradation rates of partially N-acetylated chitosans in human serum,” Carbohydrate Research, Mar. 1997, pp. 99-101, 299. |
Haroun-Bouhedja, F. et al., “In Vitro Effects of Fucans on MDA-MB231 Tumor Cell Adhesion and Invasion,” Anticancer Res., Jul.-Aug. 2002, pp. 2285-2292, 22(4). |
Scheidbach, H. et al., “In vivo studies comparing the biocompatibility of various polypropylene meshes and their handling properties during endoscopic total extraperitoneal (TEP) patchplasty: An experimental study in pigs,” Surg. Endosc., Feb. 2004, pp. 211-220,18(2). |
Blondin, C. et al., “Inhibition of Complement Activation by Natural Sulfated Polysaccharides (Fucans) from Brown Seaweed,” Molecular Immuol., Mar. 1994, pp. 247-253, 31(4). |
Zvyagintseva, T. et al., “Inhibition of complement activation by water-soluble polysaccharides of some far-eastern brown seaweeds,” Comparative Biochem and Physiol, Jul. 2000, pp. 209-215,126(3). |
Rosen, M. et al., “Laparoscopic component separation in the single-stage treatment of infected abdominal wall prosthetic removal,” Hernia, 2007, pp. 435-440, 11, published online Jul. 2007. |
Amid, P., “Lichtenstein tension-free hernioplasty: Its inception, evolution, and principles,” Hernia, 2004; pp. 1-7, 8, published online Sep. 2003. |
Boisson-Vidal, C. et al., “Neoangiogenesis Induced by Progenitor Endothelial Cells: Effect of Fucoidan From Marine Algae,” Cardiovascular & Hematological Agents in Medicinal Chem., Jan. 2007, pp. 67-77, 5(1). |
O'Dwyer, P. et al., “Randomized clinical trial assessing impact of a lightweight or heavyweight mesh on chronic pain after inguinal hernia repair,” Br. J. Surg., Feb. 2005, pp. 166-170, 92(2). |
Muzzarelli, R. et al., “Reconstruction of parodontal tissue with chitosan,” Biomaterials, Nov. 1989, pp. 598-604, 10. |
Haroun-Bouhedja, F. et al., “Relationship between sulfate groups and biological activities of fucans,” Thrombosis Res., Dec. 2000, pp. 453-459, 100(5). |
Blondin, C. et al., “Relationships between chemical characteristics and anticomplementary activity of fucans,” Biomaterials, Mar. 1996, pp. 597-603, 17(6). |
Strand, S. et al., “Screening of Chitosans and Conditions for Bacterial Flocculation,” Biomacromolecules, Mar. 2001, 126-133, 2. |
Kanabar, V. et al., “Some structural determinants of the antiproliferative effect of heparin-like molecules on human airway smooth muscle,” Br. J. Pharmacol., Oct. 2005, pp. 370-777, 146(3). |
Hirano, S. et al., “The blood biocompatibility of chitosan and N-acylchitosans,” J. Biomed. Mater. Res., Apr. 1985, 413-417, 19. |
Rao, B. et al., “Use of chitosan as a biomaterial: Studies on its safety and hemostatic potential,” J. Biomed. Mater. Res., Jan. 1997, pp. 21-28, 34. |
Prokop, A. et al., “Water Soluble Polymers for Immunoisolation I: Complex Coacevation and Cytotoxicity,” Advances in Polymer Science, Jul. 1998, pp. 1-51, 136. |
Collins, R. et al., “Use of collagen film as a dural substitute: Preliminary animal studies,” Journal of Biomedical Materials Research, Feb. 1991, pp. 267-276, vol. 25. |
Dr. S. Raz, “The Karl Mayer Guide to Tehnical Textiles,” Jan. 2000, pp. 1-36, Obertshausen, Germany. |
Chen, G. et al., “A Hybrid Network of Synthetic Polymer Mesh and Collagen Sponge,” The Royal Society of Chemistry 2000, Chem. Commun., Jul. 2000, pp. 1505-1506. |
European Office Action issued in corresponding European Patent Application No. 13774096.5 dated Oct. 4, 2016, 5 pages. |
European Office Action dated Apr. 11, 2016 in corresponding European Patent Application No. 13774096.5, 6 pages. |
International Search Report for PCT/EP13/069860 date of completion is Jan. 15, 2014 (3 pages). |
Number | Date | Country | |
---|---|---|---|
20150238299 A1 | Aug 2015 | US |